Blood Facsimile

Rene McCarthy · 2026 · $17.99 · Action · deal grade B

Measured on 2026-09-21 17:16 UTC, 14 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

Estimated net residual revenue: $445 to $667 per month
Opportunity: $723 per month at x1.30 dormancy
Estimated lifetime owners: 2.4k
98% positive across 64 reviews · 3.7 reviews/month

Why it's flagged

Developer active, last post 6 months ago
Last build shipped 6 months ago
Store page localized in only 1 language(s)
Last discounted 2 months ago, 2 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-09-08; the live figures above take precedence over any numbers in it.

Blood Facsimile is an early-access action game built on atmospheric, deliberately paced level exploration with a dreamlike visual and tactile aesthetic.

This title sits in a narrow but genuine space: a solo-dev EA project with near-universal player sentiment, solid playtime depth, and minimal marketing footprint. The case for acquisition is thin (it's pre-1.0, single-title studio, tiny install base), but the case for quiet publishing partnership or revival campaign is stronger. Players explicitly want more enemy variety and discoverable content, suggesting the game is mechanically sound but content-starved. If the developer is open to external support, modest investment in level design and enemy variety could unlock wider appeal without wholesale redesign. Most realistic play: publishing.

Risk: Peak concurrent players remains at 2 in the last 30 days, indicating severe discoverability or word-of-mouth headwinds despite high review positivity.
Risk: Early-access status and single-developer model create execution risk if development stalls or focus shifts.
Risk: Niche aesthetic and deliberately slow pacing will not appeal to mainstream action players; audience ceiling may be small even with perfect marketing.

This case as Markdown · Estimates carry ±30-50% error per title.